Analysis of Xq27-28 linkage in the international consortium for prostate cancer genetics (ICPCG) families

BMC Medical Genetics

Volumn 13, Issue , 2012, Pages

  Bailey Wilson, Joan E ^a,g,ab   Childs, Erica J ^a,b   Cropp, Cheryl D ^a   Schaid, Daniel J ^c   Xu, Jianfeng ^d   Camp, Nicola J ^e   Cannon Albright, Lisa A ^e,f   Farnham, James M ^e   George, Asha ^a,g,h   Powell, Isaac ^g,i   Carpten, John D ^g,j   Giles, Graham G ^k,l,m   Hopper, John L ^k,m   Severi, Gianluca ^k,l,m   English, Dallas R ^k,l,m   Foulkes, William D ^k,n   Mæhle, Lovise ^k,o   Møller, Pål ^k,o   Eeles, Rosalind ^k,p   Easton, Douglas ^k,q   Guy, Michelle ^k,p   Edwards, Steve ^k,p   Badzioch, Michael D ^k,r   Whittemore, Alice S ^s,t,u   Oakley Girvan, Ingrid ^s,t,u,ai   Hsieh, Chih Lin ^s,v   Dimitrov, Latchezar ^d   Stanford, Janet L ^w   Karyadi, Danielle M ^a,w   Deutsch, Kerry ^w,x   McIntosh, Laura ^w   Ostrander, Elaine A ^a,w   Wiley, Kathleen E ^y   Isaacs, Sarah D ^y   Walsh, Patrick C ^y   Thibodeau, Stephen N ^c   McDonnell, Shannon K ^c   Hebbring, Scott ^c   Lange, Ethan M ^z,aa   Cooney, Kathleen A ^z   Tammela, Teuvo L J ^ab,ac   Schleutker, Johanna ^ab,ac   Maier, Christiane ^ad   Bochum, Sylvia ^ad   Hoegel, Josef ^ad   Grönberg, Henrik ^ae   Wiklund, Fredrik ^ae   Emanuelsson, Monica ^af   Cancel Tassin, Geraldine ^ag   Valeri, Antoine ^ag   Cussenot, Olivier ^ag,ah   Isaacs, William B ^y   more..

^a NATIONAL HUMAN GENOME RESEARCH INSTITUTE   (United States)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^c MAYO CLINIC   (United States)

^d WAKE FOREST SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^f VETERANS AFFAIRS MEDICAL CENTER   (United States)

^g African American Hereditary Prostate Cancer ICPCG Group   (United States)

^h FOX CHASE CANCER CENTER   (United States)

ⁱ WAYNE STATE UNIVERSITY   (United States)

^j TRANSLATIONAL GENOMICS RESEARCH INSTITUTE   (United States)

^k ACTANE consortium   (Australia)

^l CANCER EPIDEMIOLOGY CENTRE   (Australia)

^m UNIVERSITY OF MELBOURNE   (Australia)

ⁿ MCGILL UNIVERSITY   (Canada)

^o OSLO UNIVERSITY HOSPITAL   (Norway)

^p INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^q IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

^r UNIVERSITY OF WASHINGTON MEDICAL CENTER   (United States)

^s BC/CA/HI ICPCG Group   (United States)

^t STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^u STANFORD CANCER INSTITUTE   (United States)

^v UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^w Fred Hutchinson Cancer Research Center   (United States)

^x INSTITUTE FOR SYSTEMS BIOLOGY   (United States)

^y DEPARTMENT OF PATHOLOGY   (United States)

^z UNIVERSITY OF MICHIGAN   (United States)

^aa UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^ab TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

^ac TAMPERE UNIVERSITY HOSPITAL   (Finland)

^ad UNIVERSITY OF ULM   (Germany)

^ae KAROLINSKA INSTITUTE   (Sweden)

^af UMEÅ UNIVERSITY   (Sweden)

^ag CeRePP ICPCG Group   (France)

^ah ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

^ai CANCER PREVENTION INSTITUTE OF CALIFORNIA   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ALLELE; ALLELE SHARING LOD SCORE; ARTICLE; CANCER GENETICS; CANCER INVASION; CANCER PATIENT; CHROMOSOME ABERRATION; CHROMOSOME XQ; CHROMOSOME XQ27-28; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; FAMILY; GENE MAPPING; GENETIC ANALYSIS; HEREDITY; HETEROGENEITY LOD SCORE; HUMAN; MAJOR CLINICAL STUDY; MALE; META ANALYSIS (TOPIC); MICROSATELLITE MARKER; NONPARAMETRIC TEST; ONSET AGE; PARAMETERS; PROSTATE CANCER; RISK FACTOR; SCORING SYSTEM; STATISTICAL ANALYSIS; X CHROMOSOME LINKAGE;

ALLELES; CHROMOSOMES, HUMAN, X; GENETIC LINKAGE; GENOME-WIDE ASSOCIATION STUDY; HUMANS; MALE; MICROSATELLITE REPEATS; PROSTATIC NEOPLASMS;

EID: 84862273373     PISSN: None     EISSN: 14712350     Source Type: Journal    
DOI: 10.1186/1471-2350-13-46     Document Type: Article

References (64)

1. Nelson WG, De Marzo AM, Isaacs WB. Prostate cancer. N Engl J Med 2003, 349(4):366-381. 10.1056/NEJMra021562, 12878745.
2. Jemal A, Siegel R, Xu J, Ward E. Cancer statistics, 2010. CA Cancer J Clin 2010, 60(5):277-300. 10.3322/caac.20073, 20610543.
3. Smith JR, Freije D, Carpten JD, Gronberg H, Xu J, Isaacs SD, Brownstein MJ, Bova GS, Guo H, Bujnovszky P, Nusskern DR, Damber JE, Bergh A, Emanuelsson M, Kallioniemi OP, Walker-Daniels J, Bailey-Wilson JE, Beaty TH, Meyers DA, Walsh PC, Collins FS, Trent JM, Isaacs WB. Major susceptibility locus for prostate cancer on chromosome 1 suggested by a genome-wide search. Science 1996, 274(5291):1371-1374. 10.1126/science.274.5291.1371, 8910276.
4. Xu J. Combined analysis of hereditary prostate cancer linkage to 1q24-25: results from 772 hereditary prostate cancer families from the International Consortium for Prostate Cancer Genetics. Am J Hum Genet 2000, 66(3):945-957. 10.1086/302807, 1288175, 10712209.
5. Carpten J, Nupponen N, Isaacs S, Sood R, Robbins C, Xu J, Faruque M, Moses T, Ewing C, Gillanders E, Hu P, Bujnovszky P, Makalowska I, Baffoe-Bonnie A, Faith D, Smith J, Stephan D, Wiley K, Brownstein M, Gildea D, Kelly B, Jenkins R, Hostetter G, Matikainen M, Schleutker J, Klinger K, Connors T, Xiang Y, Wang Z, De Marzo A, Papadopoulos N, Kallioniemi OP, Burk R, Meyers D, Gronberg H, Meltzer P, Silverman R, Bailey-Wilson J, Walsh P, Isaacs W, Trent J. Germline mutations in the ribonuclease L gene in families showing linkage with HPC1. Nat Genet 2002, 30(2):181-184. 10.1038/ng823, 11799394.
6. Agalliu I, Leanza SM, Smith L, Trent JM, Carpten JD, Bailey-Wilson JE, Burk RD. Contribution of HPC1 (RNASEL) and HPCX variants to prostate cancer in a founder population. Prostate 2010, 70(15):1716-1727. 10.1002/pros.21207, 3404133, 20564318.
7. Meyer MS, Penney KL, Stark JR, Schumacher FR, Sesso HD, Loda M, Fiorentino M, Finn S, Flavin RJ, Kurth T, Price AL, Giovannucci EL, Fall K, Stampfer MJ, Ma J, Mucci LA. Genetic variation in RNASEL associated with prostate cancer risk and progression. Carcinogenesis 2010, 31(9):1597-1603. 10.1093/carcin/bgq132, 2930803, 20576793.
8. Fesinmeyer MD, Kwon EM, Fu R, Ostrander EA, Stanford JL. Genetic variation in RNASEL and risk for prostate cancer in a population-based case-control study. Prostate 2011, 71(14):1538-1547.
9. Mi YY, Zhu LJ, Wu S, Feng NH. An update analysis of two polymorphisms in encoding ribonuclease L gene and prostate cancer risk: involving 13,372 cases and 11,953 controls. Genes Nutr 2011, 6(4):397-402. 10.1007/s12263-011-0221-2, 3197849, 21499914.
10. Wei B, Xu Z, Ruan J, Zhu M, Jin K, Zhou D, Yan Z, Xuan F, Zhou H, Huang X, Zhang J, Lu P, Shao J. RNASEL Asp541Glu and Arg462Gln polymorphisms in prostate cancer risk: evidences from a meta-analysis. Mol Biol Rep 2012, 39(3):2347-2353. 10.1007/s11033-011-0985-x, 21656378.
11. Baffoe-Bonnie AB, Smith JR, Stephan DA, Schleutker J, Carpten JD, Kainu T, Gillanders EM, Matikainen M, Teslovich TM, Tammela T, Sood R, Balshem AM, Scarborough SD, Xu J, Isaacs WB, Trent JM, Kallioniemi OP, Bailey-Wilson JE. A major locus for hereditary prostate cancer in Finland: localization by linkage disequilibrium of a haplotype in the HPCX region. Hum Genet 2005, 117(4):307-316. 10.1007/s00439-005-1306-z, 15906096.
12. Bergthorsson JT, Johannesdottir G, Arason A, Benediktsdottir KR, Agnarsson BA, Bailey-Wilson JE, Gillanders E, Smith J, Trent J, Barkardottir RB. Analysis of HPC1, HPCX, and PCaP in Icelandic hereditary prostate cancer. Hum Genet 2000, 107(4):372-375. 10.1007/s004390000384, 11129338.
13. Berry R, Schaid DJ, Smith JR, French AJ, Schroeder JJ, McDonnell SK, Peterson BJ, Wang ZY, Carpten JD, Roberts SG, Tester DJ, Blute ML, Trent JM, Thibodeau SN. Linkage analyses at the chromosome 1 loci 1q24-25 (HPC1), 1q42.2-43 (PCAP), and 1p36 (CAPB) in families with hereditary prostate cancer. Am J Hum Genet 2000, 66(2):539-546. 10.1086/302771, 1288107, 10677314.
14. Berry R, Schroeder JJ, French AJ, McDonnell SK, Peterson BJ, Cunningham JM, Thibodeau SN, Schaid DJ. Evidence for a prostate cancer-susceptibility locus on chromosome 20. Am J Hum Genet 2000, 67(1):82-91. 10.1086/302994, 1287105, 10820130.
15. Berthon P, Valeri A, Cohen-Akenine A, Drelon E, Paiss T, Wohr G, Latil A, Millasseau P, Mellah I, Cohen N, Blanche H, Bellane-Chantelot C, Demenais F, Teillac P, Le Duc A, de Petriconi R, Hautmann R, Chumakov I, Bachner L, Maitland NJ, Lidereau R, Vogel W, Fournier G, Mangin P, Cussenot O, et al. Predisposing gene for early-onset prostate cancer, localized on chromosome 1q42.2-43. Am J Hum Genet 1998, 62(6):1416-1424. 10.1086/301879, 1377158, 9585607.
16. Bock CH, Cunningham JM, McDonnell SK, Schaid DJ, Peterson BJ, Pavlic RJ, Schroeder JJ, Klein J, French AJ, Marks A, Thibodeau SN, Lange EM, Cooney KA. Analysis of the prostate cancer-susceptibility locus HPC20 in 172 families affected by prostate cancer. Am J Hum Genet 2001, 68(3):795-801. 10.1086/318797, 1274493, 11179028.
17. Cancel-Tassin G, Latil A, Valeri A, Guillaume E, Mangin P, Fournier G, Berthon P, Cussenot O. No evidence of linkage to HPC20 on chromosome 20q13 in hereditary prostate cancer. Int J Cancer 2001, 93(3):455-456. 10.1002/ijc.1345, 11433415.
18. Cancel-Tassin G, Latil A, Valeri A, Mangin P, Fournier G, Berthon P, Cussenot O. PCAP is the major known prostate cancer predisposing locus in families from south and west Europe. Eur J Hum Genet 2001, 9(2):135-142. 10.1038/sj.ejhg.5200592, 11313747.
19. Cunningham JM, McDonnell SK, Marks A, Hebbring S, Anderson SA, Peterson BJ, Slager S, French A, Blute ML, Schaid DJ, Thibodeau SN. Genome linkage screen for prostate cancer susceptibility loci: results from the Mayo Clinic Familial Prostate Cancer Study. Prostate 2003, 57(4):335-346. 10.1002/pros.10308, 14601030.
20. Edwards S, Meitz J, Eles R, Evans C, Easton D, Hopper J, Giles G, Foulkes WD, Narod S, Simard J, Badzioch M, Mahle L. Results of a genome-wide linkage analysis in prostate cancer families ascertained through the ACTANE consortium. Prostate 2003, 57(4):270-279.
21. Farnham JM, Camp NJ, Swensen J, Tavtigian SV, Albright LA. Confirmation of the HPCX prostate cancer predisposition locus in large Utah prostate cancer pedigrees. Hum Genet 2005, 116(3):179-185. 10.1007/s00439-004-1220-9, 15592687.
22. Friedrichsen DM, Stanford JL, Isaacs SD, Janer M, Chang BL, Deutsch K, Gillanders E, Kolb S, Wiley KE, Badzioch MD, Zheng SL, Walsh PC, Jarvik GP, Hood L, Trent JM, Isaacs WB, Ostrander EA, Xu J. Identification of a prostate cancer susceptibility locus on chromosome 7q11-21 in Jewish families. Proc Natl Acad Sci U S A 2004, 101(7):1939-1944. 10.1073/pnas.0308336100, 357031, 14769943.
23. Gibbs M, Stanford JL, McIndoe RA, Jarvik GP, Kolb S, Goode EL, Chakrabarti L, Schuster EF, Buckley VA, Miller EL, Brandzel S, Li S, Hood L, Ostrander EA. Evidence for a rare prostate cancer-susceptibility locus at chromosome 1p36. Am J Hum Genet 1999, 64(3):776-787. 10.1086/302287, 1377795, 10053012.
24. Hsieh CL, Oakley-Girvan I, Balise RR, Halpern J, Gallagher RP, Wu AH, Kolonel LN, O'Brien LE, Lin IG, Van Den Berg DJ, Teh CZ, West DW, Whittemore AS. A genome screen of families with multiple cases of prostate cancer: evidence of genetic heterogeneity. Am J Hum Genet 2001, 69(1):148-158. 10.1086/321281, 1226029, 11404817.
25. Janer M, Friedrichsen DM, Stanford JL, Badzioch MD, Kolb S, Deutsch K, Peters MA, Goode EL, Welti R, DeFrance HB, Iwasaki L, Li S, Hood L, Ostrander EA, Jarvik GP. Genomic scan of 254 hereditary prostate cancer families. Prostate 2003, 57(4):309-319. 10.1002/pros.10305, 14601027.
26. Johns LE, Houlston RS. A systematic review and meta-analysis of familial prostate cancer risk. BJU Int 2003, 91(9):789-794. 10.1046/j.1464-410X.2003.04232.x, 12780833.
27. McIndoe RA, Stanford JL, Gibbs M, Jarvik GP, Brandzel S, Neal CL, Li S, Gammack JT, Gay AA, Goode EL, Hood L, Ostrander EA. Linkage analysis of 49 high-risk families does not support a common familial prostate cancer-susceptibility gene at 1q24-25. Am J Hum Genet 1997, 61(2):347-353. 10.1086/514853, 1715908, 9311739.
28. Neville PJ, Conti DV, Krumroy LM, Catalona WJ, Suarez BK, Witte JS, Casey G. Prostate cancer aggressiveness locus on chromosome segment 19q12-q13.1 identified by linkage and allelic imbalance studies. Genes Chromosomes Cancer 2003, 36(4):332-339. 10.1002/gcc.10165, 12619157.
29. Neville PJ, Conti DV, Paris PL, Levin H, Catalona WJ, Suarez BK, Witte JS, Casey G. Prostate cancer aggressiveness locus on chromosome 7q32-q33 identified by linkage and allelic imbalance studies. Neoplasia 2002, 4(5):424-431. 10.1038/sj.neo.7900254, 1564121, 12192601.
30. Ostrander EA, Stanford JL. Genetics of prostate cancer: too many loci, too few genes. Am J Hum Genet 2000, 67(6):1367-1375. 10.1086/316916, 1287913, 11067781.
31. Paiss T, Worner S, Kurtz F, Haeussler J, Hautmann RE, Gschwend JE, Herkommer K, Vogel W. Linkage of aggressive prostate cancer to chromosome 7q31-33 in German prostate cancer families. Eur J Hum Genet 2003, 11(1):17-22. 10.1038/sj.ejhg.5200898, 12529701.
32. Schleutker J, Baffoe-Bonnie AB, Gillanders E, Kainu T, Jones MP, Freas-Lutz D, Markey C, Gildea D, Riedesel E, Albertus J, Gibbs KD, Matikainen M, Koivisto PA, Tammela T, Bailey-Wilson JE, Trent JM, Kallioniemi OP. Genome-wide scan for linkage in finnish hereditary prostate cancer (HPC) families identifies novel susceptibility loci at 11q14 and 3p25-26. Prostate 2003, 57(4):280-289. 10.1002/pros.10302, 14601024.
33. Schleutker J, Matikainen M, Smith J, Koivisto P, Baffoe-Bonnie A, Kainu T, Gillanders E, Sankila R, Pukkala E, Carpten J, Stephan D, Tammela T, Brownstein M, Bailey-Wilson J, Trent J, Kallioniemi OP. A genetic epidemiological study of hereditary prostate cancer (HPC) in Finland: frequent HPCX linkage in families with late-onset disease. Clin Cancer Res 2000, 6(12):4810-4815.
34. Slager SL, Schaid DJ, Cunningham JM, McDonnell SK, Marks AF, Peterson BJ, Hebbring SJ, Anderson S, French AJ, Thibodeau SN. Confirmation of linkage of prostate cancer aggressiveness with chromosome 19q. Am J Hum Genet 2003, 72(3):759-762. 10.1086/368230, 1180252, 12563560.
35. Tavtigian SV, Simard J, Teng DH, Abtin V, Baumgard M, Beck A, Camp NJ, Carillo AR, Chen Y, Dayananth P, Desrochers M, Dumont M, Farnham JM, Frank D, Frye C, Ghaffari S, Gupte JS, Hu R, Iliev D, Janecki T, Kort EN, Laity KE, Leavitt A, Leblanc G, McArthur-Morrison J, Pederson A, Penn B, Peterson KT, Reid JE, Richards S, Schroeder M, Smith R, Snyder SC, Swedlund B, Swensen J, Thomas A, Tranchant M, Woodland AM, Labrie F, Skolnick MH, Neuhausen S, Rommens J, Cannon-Albright LA. A candidate prostate cancer susceptibility gene at chromosome 17p. Nat Genet 2001, 27(2):172-180. 10.1038/84808, 11175785.
36. Witte JS, Goddard KA, Conti DV, Elston RC, Lin J, Suarez BK, Broman KW, Burmester JK, Weber JL, Catalona WJ. Genomewide scan for prostate cancer-aggressiveness loci. Am J Hum Genet 2000, 67(1):92-99. 10.1086/302960, 1287106, 10825281.
37. Xu J, Gillanders EM, Isaacs SD, Chang BL, Wiley KE, Zheng SL, Jones M, Gildea D, Riedesel E, Albertus J, Freas-Lutz D, Markey C, Meyers DA, Walsh PC, Trent JM, Isaacs WB. Genome-wide scan for prostate cancer susceptibility genes in the Johns Hopkins hereditary prostate cancer families. Prostate 2003, 57(4):320-325. 10.1002/pros.10306, 14601028.
38. Xu J, Meyers D, Freije D, Isaacs S, Wiley K, Nusskern D, Ewing C, Wilkens E, Bujnovszky P, Bova GS, Walsh P, Isaacs W, Schleutker J, Matikainen M, Tammela T, Visakorpi T, Kallioniemi OP, Berry R, Schaid D, French A, McDonnell S, Schroeder J, Blute M, Thibodeau S, Gronberg H, Emanuelsson M, Damber JE, Bergh A, Jonsson BA, Smith J, Bailey-Wilson J, Carpten J, Stephan D, Gillanders E, Amundson I, Kainu T, Freas-Lutz D, Baffoe-Bonnie A, Van Aucken A, Sood R, Collins F, Brownstein M, Trent J. Evidence for a prostate cancer susceptibility locus on the X chromosome. Nat Genet 1998, 20(2):175-179. 10.1038/2477, 9771711.
39. Xu J, Zheng SL, Hawkins GA, Faith DA, Kelly B, Isaacs SD, Wiley KE, Chang B, Ewing CM, Bujnovszky P, Carpten JD, Bleecker ER, Walsh PC, Trent JM, Meyers DA, Isaacs WB. Linkage and association studies of prostate cancer susceptibility: evidence for linkage at 8p22-23. Am J Hum Genet 2001, 69(2):341-350. 10.1086/321967, 1235306, 11443539.
40. Zheng SL, Xu J, Isaacs SD, Wiley K, Chang B, Bleecker ER, Walsh PC, Trent JM, Meyers DA, Isaacs WB. Evidence for a prostate cancer linkage to chromosome 20 in 159 hereditary prostate cancer families. Hum Genet 2001, 108(5):430-435. 10.1007/s004390100513, 11409871.
41. Easton DF, Schaid DJ, Whittemore AS, Isaacs WJ. Where are the prostate cancer genes?-A summary of eight genome wide searches. Prostate 2003, 57(4):261-269. 10.1002/pros.10300, 14601022.
42. Schaid DJ. The complex genetic epidemiology of prostate cancer. Hum Mol Genet 2004, 13(1):R103-R121. 10.1093/hmg/ddh072, 14749351.
43. Thomas G, Jacobs KB, Yeager M, Kraft P, Wacholder S, Orr N, Yu K, Chatterjee N, Welch R, Hutchinson A, Crenshaw A, Cancel-Tassin G, Staats BJ, Wang Z, Gonzalez-Bosquet J, Fang J, Deng X, Berndt SI, Calle EE, Feigelson HS, Thun MJ, Rodriguez C, Albanes D, Virtamo J, Weinstein S, Schumacher FR, Giovannucci E, Willett WC, Cussenot O, Valeri A, Andriole GL, Crawford ED, Tucker M, Gerhard DS, Fraumeni JF, Hoover R, Hayes RB, Hunter DJ, Chanock SJ. Multiple loci identified in a genome-wide association study of prostate cancer. Nat Genet 2008, 40(3):310-315. 10.1038/ng.91, 18264096.
44. Yeager M, Orr N, Hayes RB, Jacobs KB, Kraft P, Wacholder S, Minichiello MJ, Fearnhead P, Yu K, Chatterjee N, Wang Z, Welch R, Staats BJ, Calle EE, Feigelson HS, Thun MJ, Rodriguez C, Albanes D, Virtamo J, Weinstein S, Schumacher FR, Giovannucci E, Willett WC, Cancel-Tassin G, Cussenot O, Valeri A, Andriole GL, Gelmann EP, Tucker M, Gerhard DS, Fraumeni JF, Hoover R, Hunter DJ, Chanock SJ, Thomas G. Genome-wide association study of prostate cancer identifies a second risk locus at 8q24. Nat Genet 2007, 39(5):645-649. 10.1038/ng2022, 17401363.
45. Gudmundsson J, Sulem P, Manolescu A, Amundadottir LT, Gudbjartsson D, Helgason A, Rafnar T, Bergthorsson JT, Agnarsson BA, Baker A, Sigurdsson A, Benediktsdottir KR, Jakobsdottir M, Xu J, Blondal T, Kostic J, Sun J, Ghosh S, Stacey SN, Mouy M, Saemundsdottir J, Backman VM, Kristjansson K, Tres A, Partin AW, Albers-Akkers MT, Godino-Ivan Marcos J, Walsh PC, Swinkels DW, Navarrete S, Isaacs SD, Aben KK, Graif T, Cashy J, Ruiz-Echarri M, Wiley KE, Suarez BK, Witjes JA, Frigge M, Ober C, Jonsson E, Einarsson GV, Mayordomo JI, Kiemeney LA, Isaacs WB, Catalona WJ, Barkardottir RB, Gulcher JR, Thorsteinsdottir U, Kong A, Stefansson K. Genome-wide association study identifies a second prostate cancer susceptibility variant at 8q24. Nat Genet 2007, 39(5):631-637. 10.1038/ng1999, 17401366.
46. Easton DF, Eeles RA. Genome-wide association studies in cancer. Hum Mol Genet 2008, 17(R2):R109-R115. 10.1093/hmg/ddn287, 18852198.
47. Eeles RA, Kote-Jarai Z, Giles GG, Olama AA, Guy M, Jugurnauth SK, Mulholland S, Leongamornlert DA, Edwards SM, Morrison J, Field HI, Southey MC, Severi G, Donovan JL, Hamdy FC, Dearnaley DP, Muir KR, Smith C, Bagnato M, Ardern-Jones AT, Hall AL, O'Brien LT, Gehr-Swain BN, Wilkinson RA, Cox A, Lewis S, Brown PM, Jhavar SG, Tymrakiewicz M, Lophatananon A, Bryant SL, Horwich A, Huddart RA, Khoo VS, Parker CC, Woodhouse CJ, Thompson A, Christmas T, Ogden C, Fisher C, Jamieson C, Cooper CS, English DR, Hopper JL, Neal DE, Easton DF. Multiple newly identified loci associated with prostate cancer susceptibility. Nat Genet 2008, 40(3):316-321. 10.1038/ng.90, 18264097.
48. Gudmundsson J, Sulem P, Gudbjartsson DF, Blondal T, Gylfason A, Agnarsson BA, Benediktsdottir KR, Magnusdottir DN, Orlygsdottir G, Jakobsdottir M, Stacey SN, Sigurdsson A, Wahlfors T, Tammela T, Breyer JP, McReynolds KM, Bradley KM, Saez B, Godino J, Navarrete S, Fuertes F, Murillo L, Polo E, Aben KK, van Oort IM, Suarez BK, Helfand BT, Kan D, Zanon C, Frigge ML, Kristjansson K, Gulcher JR, Einarsson GV, Jonsson E, Catalona WJ, Mayordomo JI, Kiemeney LA, Smith JR, Schleutker J, Barkardottir RB, Kong A, Thorsteinsdottir U, Rafnar T, Stefansson K. Genome-wide association and replication studies identify four variants associated with prostate cancer susceptibility. Nat Genet 2009, 41(10):1122-1126. 10.1038/ng.448, 19767754.
49. Eeles RA, Kote-Jarai Z, Al Olama AA, Giles GG, Guy M, Severi G, Muir K, Hopper JL, Henderson BE, Haiman CA, Schleutker J, Hamdy FC, Neal DE, Donovan JL, Stanford JL, Ostrander EA, Ingles SA, John EM, Thibodeau SN, Schaid D, Park JY, Spurdle A, Clements J, Dickinson JL, Maier C, Vogel W, Dork T, Rebbeck TR, Cooney KA, Cannon-Albright L, Chappuis PO, Hutter P, Zeegers M, Kaneva R, Zhang HW, Lu YJ, Foulkes WD, English DR, Leongamornlert DA, Tymrakiewicz M, Morrison J, Ardern-Jones AT, Hall AL, O'Brien LT, Wilkinson RA, Saunders EJ, Page EC, Sawyer EJ, Edwards SM, Dearnaley DP, Horwich A, Huddart RA, Khoo VS, Parker CC, Van As N, Woodhouse CJ, Thompson A, Christmas T, Ogden C, Cooper CS, Southey MC, Lophatananon A, Liu JF, Kolonel LN, Le Marchand L, Wahlfors T, Tammela TL, Auvinen A, Lewis SJ, Cox A, FitzGerald LM, Koopmeiners JS, Karyadi DM, Kwon EM, Stern MC, Corral R, Joshi AD, Shahabi A, McDonnell SK, Sellers TA, Pow-Sang J, Chambers S, Aitken J, Gardiner RA, Batra J, Kedda MA, Lose F, Polanowski A, Patterson B, Serth J, Meyer A, Luedeke M, Stefflova K, Ray AM, Lange EM, Farnham J, Khan H, Slavov C, Mitkova A, Cao G, Easton DF. Identification of seven new prostate cancer susceptibility loci through a genome-wide association study. Nat Genet 2009, 41(10):1116-1121. 10.1038/ng.450, 2846760, 19767753.
50. Varghese JS, Easton DF. Genome-wide association studies in common cancers-what have we learnt?. Curr Opin Genet Dev 2010, 20(3):201-209. 10.1016/j.gde.2010.03.012, 20418093.
51. Bochum S, Paiss T, Vogel W, Herkommer K, Hautmann R, Haeussler J. Confirmation of the prostate cancer susceptibility locus HPCX in a set of 104 German prostate cancer families. Prostate 2002, 52(1):12-19. 10.1002/pros.10078, 11992616.
52. Peters MA, Jarvik GP, Janer M, Chakrabarti L, Kolb S, Goode EL, Gibbs M, DuBois CC, Schuster EF, Hood L, Ostrander EA, Stanford JL. Genetic linkage analysis of prostate cancer families to Xq27-28. Hum Hered 2001, 51(1-2):107-113.
53. Lange EM, Chen H, Brierley K, Perrone EE, Bock CH, Gillanders E, Ray ME, Cooney KA. Linkage analysis of 153 prostate cancer families over a 30-cM region containing the putative susceptibility locus HPCX. Clin Cancer Res 1999, 5(12):4013-4020.
54. Kouprina N, Pavlicek A, Noskov VN, Solomon G, Otstot J, Isaacs W, Carpten JD, Trent JM, Schleutker J, Barrett JC, Jurka J, Larionov V. Dynamic structure of the SPANX gene cluster mapped to the prostate cancer susceptibility locus HPCX at Xq27. Genome Res 2005, 15(11):1477-1486. 10.1101/gr.4212705, 1310635, 16251457.
55. Kouprina N, Noskov VN, Solomon G, Otstot J, Isaacs W, Xu J, Schleutker J, Larionov V. Mutational analysis of SPANX genes in families with X-linked prostate cancer. Prostate 2007, 67(8):820-828. 10.1002/pros.20561, 17373721.
56. Gudmundsson J, Sulem P, Rafnar T, Bergthorsson JT, Manolescu A, Gudbjartsson D, Agnarsson BA, Sigurdsson A, Benediktsdottir KR, Blondal T, Jakobsdottir M, Stacey SN, Kostic J, Kristinsson KT, Birgisdottir B, Ghosh S, Magnusdottir DN, Thorlacius S, Thorleifsson G, Zheng SL, Sun J, Chang BL, Elmore JB, Breyer JP, McReynolds KM, Bradley KM, Yaspan BL, Wiklund F, Stattin P, Lindstrom S, Adami HO, McDonnell SK, Schaid DJ, Cunningham JM, Wang L, Cerhan JR, St Sauver JL, Isaacs SD, Wiley KE, Partin AW, Walsh PC, Polo S, Ruiz-Echarri M, Navarrete S, Fuertes F, Saez B, Godino J, Weijerman PC, Swinkels DW, Aben KK, Witjes JA, Suarez BK, Helfand BT, Frigge ML, Kristjansson K, Ober C, Jonsson E, Einarsson GV, Xu J, Gronberg H, Smith JR, Thibodeau SN, Isaacs WB, Catalona WJ, Mayordomo JI, Kiemeney LA, Barkardottir RB, Gulcher JR, Thorsteinsdottir U, Kong A, Stefansson K. Common sequence variants on 2p15 and Xp11.22 confer susceptibility to prostate cancer. Nat Genet 2008, 40(3):281-283. 10.1038/ng.89, 18264098.
57. Carter BS, Beaty TH, Steinberg GD, Childs B, Walsh PC. Mendelian inheritance of familial prostate cancer. Proc Natl Acad Sci U S A 1992, 89(8):3367-3371. 10.1073/pnas.89.8.3367, 48868, 1565627.
58. Carter BS, Bova GS, Beaty TH, Steinberg GD, Childs B, Isaacs WB, Walsh PC. Hereditary prostate cancer: epidemiologic and clinical features. J Urol 1993, 150(3):797-802.
59. Schaid DJ, Chang BL. Description of the International Consortium For Prostate Cancer Genetics, and failure to replicate linkage of hereditary prostate cancer to 20q13. Prostate 2005, 63(3):276-290. 10.1002/pros.20198, 15599943.
60. Kong A, Gudbjartsson DF, Sainz J, Jonsdottir GM, Gudjonsson SA, Richardsson B, Sigurdardottir S, Barnard J, Hallbeck B, Masson G, Shlien A, Palsson ST, Frigge ML, Thorgeirsson TE, Gulcher JR, Stefansson K. A high-resolution recombination map of the human genome. Nat Genet 2002, 31(3):241-247.
61. Kong A, Cox NJ. Allele-sharing models: LOD scores and accurate linkage tests. Am J Hum Genet 1997, 61(5):1179-1188. 10.1086/301592, 1716027, 9345087.
62. Kruglyak L, Daly MJ, Reeve-Daly MP, Lander ES. Parametric and nonparametric linkage analysis: a unified multipoint approach. Am J Hum Genet 1996, 58(6):1347-1363. 1915045, 8651312.
63. Ott J. Analysis of Human Genetic Linkage 1999, The Johns Hopkins University Press, Baltimore.
64. Lander E, Kruglyak L. Genetic dissection of complex traits: guidelines for interpreting and reporting linkage results. Nat Genet 1995, 11(3):241-247. 10.1038/ng1195-241, 7581446.